Merck Millipore Opens New R&D Center
News Jul 15, 2013
Merck Millipore announced the opening of its new Research & Development Center for Formulation in Darmstadt, Germany. The center for Formulation combines state-of-the-art formulation, analytical and synthetic labs and a fully-equipped customer training center in a single facility. The center will accelerate growth of the company's portfolio of innovative technologies and products that overcome bioavailability and formulation challenges and will provide hands-on support to assist customers in their drug development.
"To better address the needs of our pharmaceutical customers, we are expanding our capabilities for bioavailability enhancement," said Burghard Freiberg, Senior Vice President, Pharma Chemicals Solutions. "There is a clear market need for a comprehensive set of innovative products and technologies to support bioavailability enhancement. At our new center for Formulation, we can help customers overcome formulation-related challenges, such as insufficient API performance due to poor solubility and life cycle management developments, in a more effective and efficient manner."
Expertise offered by Merck Millipore includes oral dosage formulation development and drug delivery systems. Core areas are inorganic carriers, solid dispersion formulation techniques, and development of other excipients and excipient systems. Technologies include granulation, tableting, film coating, direct compression and freeze drying. When requested by customers, formulated products can be analytically characterized in the new laboratory.
Key Cancer-Linked Proteins Thought to be ‘Undruggable’ Until NowNews
A new study published in Nature, conducted by an alliance between industry and academia involving the University of Liverpool, highlights a new approach to targeting key cancer-linked proteins, thought to be ‘undruggable’.READ MORE
Researchers Reveal How Superbug Secretes It’s ToxinNews
Monash University’s Biomedicine Discovery Institute (BDI) researchers have created the first high-resolution structure depicting a crucial part of the ‘superbug’ Pseudomonas aeruginosa. The image identifies the ‘nanomachine’ used by the highly virulent bacteria to secrete toxins, pointing the way for drug design targeting this.READ MORE
Arsenic Trioxide Could Extend Lives of Patients with Aggressive Brain CancerNews
Arsenic trioxide could be a powerful therapy that could extend the lives of certain glioblastoma patients by as much as three to four times the median expectation.READ MORE
Comments | 0 ADD COMMENT
Annual Conference on Antimicrobials and Drug Resistance
Sep 24 - Sep 25, 2018
1st Alpine Winter Conference on Medicinal and Synthetic Chemistry
Jan 28 - Feb 01, 2018